SCHEMBL14736834

SCHEMBL14736834

Cn1nc(-c2ccccc2)nc1CC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 4/20 0.50
NR1H3 Q13133 4/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
GAA P10253 1/20 0.47
KMT2A Q03164 3/20 0.46
F2 P00734 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PARP1 P09874 1/20 0.46
KDM4C Q9H3R0 2/20 0.46
PDE10A Q9Y233 4/20 0.45
TDP2 O95551 1/20 0.43
RAF1 P04049 1/20 0.43
MAP2K1 Q02750 1/20 0.43
ALDH1A1 P00352 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
ADORA1 P30542 1/20 0.41
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14736779 0.87 KDM4C (0.44) NR1H2NR1H3NPC1RAB9AKDM4C
SCHEMBL14736529 0.85 F2 (0.50) KMT2AF2PDE10APOLBCYP1A2
SCHEMBL14736860 0.81 HDAC1 (0.54) GAAKMT2AF2NPSR1
SCHEMBL14736090 0.80 PDE10A (0.49) NR1H2NR1H3RAB9AGAAKMT2A
SCHEMBL14736835 0.80 PDE10A (0.54) NR1H2NR1H3NPC1RAB9AGAA
SCHEMBL2035500 0.79 NR1H3 (0.58) NR1H2NR1H3NPC1RAB9AGAA
SCHEMBL14736193 0.78 NR1H3 (0.56) NR1H2NR1H3NPC1RAB9AGAA
Hydrochloric Acid SCHEMBL14736096 0.78 PDE10A (0.53) NR1H2NR1H3NPC1RAB9AGAA
SCHEMBL14736524 0.77 PDE10A (0.46) NR1H2NR1H3RAB9AGAAKMT2A
SCHEMBL21301566 0.77 NR1H3 (0.59) NR1H2NR1H3NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772510-B2 PDE10 modulators HOFFMANN-LA ROCHE INC. (US) 2014-07-08 US claimed
US-20130059833-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-07 US claimed
EP-2753604-B1 PDE10 MODULATORS HOFFMANN LA ROCHE (CH) 2015-08-19 EP disclosed
US-8772510-B2 PDE10 modulators HOFFMANN-LA ROCHE INC. (US) 2014-07-08 US disclosed
EP-2574607-A1 PDE10 modulators F. Hoffmann-La Roche AG (CH) 2013-04-03 EP disclosed
WO-2013034506-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-14 WO disclosed
US-20130059833-A1 PDE10 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059833-A1 PDE10 MODULATORS PDE10A, PDE5A, PDE2A NR1H2 1040/4885NR1H3 1485/4885NPC1 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.